J&J to file USFDA request to start trials for surgical robots
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have.
By Dr K. Leelamoni November 7, 2023: My cousin’s son, 46, went to a hospital in the southern Indian state of Kerala as.
HQ Team November 6, 2023: The USFDA plans to revoke a regulation authorising the use of brominated vegetable oil in food as it.
HQ Team November 6, 2023: Human activities are making the earth’s air, freshwater and soil saltier, posing an “existential threat” if the trend.
HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to.
HQ Team November 4, 2023: Scientists have discovered a possible treatment for antibiotic-resistant super gonorrhea. In a large experiment involving nearly a 1000.
HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature..
HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights.
HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.